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Introduction {#s1}
============

Tuberculosis (TB) has an impact on health worldwide, with an estimated 9.6 million people developing active TB and 1.5 million people dying from the disease in 2014 ([@c51]). TB mortality rates remain high despite adequate treatment ([@c17]; [@c39]), and the effects of environmental factors such as ambient air pollution on TB outcomes remain uncertain. The majority of the world's population is exposed to unhealthy levels of ambient air pollution, with approximately 89% living in areas where fine particulate mat-ter $< 2.5\;\mu m$ in diameter (${PM}_{2.5}$) exceeds World Health Organization (WHO) air quality standards ([@c8]), and it is estimated that ambient air pollution contributes to approximately 3.3 million premature deaths each year ([@c31]).

It has long been observed that certain inhaled toxicants are associated with pulmonary infection: Published studies as far back as 100 y ago reported associations between tobacco smoking and TB ([@c50]). There is now ample evidence to suggest that active tobacco smokers are at increased risk for TB infection, progression to active TB, and worse treatment outcomes including mortality ([@c2]; [@c22]; [@c25]; [@c32]; [@c33]; [@c44]). This evidence has led the WHO to affirm tobacco smoking as a significant TB risk factor ([@c52]).

Tobacco smoke is composed of a number of chemical compounds that are also found in traffic emissions ([@c11]; [@c18]; [@c28]), raising concerns that traffic-related air pollution (TRAP) could also be associated with adverse TB outcomes. Ambient air pollution is an established risk factor for community-acquired pneumonia ([@c14]; [@c36]; [@c54]), yet studies linking ambient air pollution to other pulmonary infections such as TB are limited. The effects of ambient air pollution on TB incidence have been investigated in a few studies with mixed findings. In a nested case--control study using a northern California managed-care database, nitrogen dioxide ($\text{NO}_{2}$) was associated with increased odds of active TB ([@c45]); in a community-based cohort study in Taipei, Taiwan, both ${PM}_{2.5}$ and $\text{NO}_{2}$ were associated with increased risk of active TB ([@c30]); and in Beijing and Hong Kong, China, outdoor ${PM}_{2.5}$ was associated with seasonal changes in TB incidence ([@c53]). However, in a time-series study in Seoul, South Korea, spikes in sulfur dioxide ($\text{SO}_{2}$) but not in particulate matter $< 10\;\mu m$ in diameter (${PM}_{10}$), $\text{NO}_{2}$, or ozone were associated with temporally related increases in TB incidence ([@c23]). The effects of ambient air pollution on TB treatment outcomes remain uncertain, and there has been only one published study to date that has examined the association of ambient air pollution with mortality during TB treatment; this study found that annual mean estimates of ${PM}_{2.5}$ were associated with increased mortality ([@c40]). Additionally, there has been only one published study to evaluate traffic proximity as a TB risk factor. This study did not find a statistically significant association between distance to the nearest major road or freeway and smear positivity among patients with pulmonary TB in Los Angeles, California ([@c24]). However, the study's small sample size and cross-sectional design preclude firm conclusions linking these traffic metrics to TB outcomes, thereby warranting a larger study with a prospective cohort study design from which causal inferences can be made.

We used proximity to road traffic volumes and proximity to traffic density as measures of traffic-related air pollution instead of individual air pollutant models because our traffic proximity models capture the mix of pollutants emitted from motor vehicles as opposed to models for individual pollutants that might provide a less-complete representation of traffic exposure. For instance, in a study evaluating the association of traffic exposures with childhood incident asthma, the effect of $\text{NO}_{2}$ on incident asthma, which had a hazard ratio (HR) of 2.17 \[95% confidence interval (CI): 1.18, 4.00\], was attenuated to 1.37 (95% CI: 0.69, 2.71) when adjusting for traffic exposure using a line source dispersion model that included distance to roadways and vehicle counts ([@c34]), suggesting that traffic proximity was a key factor for determining TRAP health effects. Furthermore, in another study comparing different TRAP exposure metrics, traffic density was found to be "reasonably consistent with the more sophisticated metrics" ([@c3]).

Both TB and ambient air pollution are significant public health issues in California. Nearly 25% of all U.S. TB cases occur in California ([@c42]), and $> 80\%$ of Californians live in counties with unhealthy ambient air concentrations of ${PM}_{2.5}$, ozone, or both ([@c1]). Additionally, the predominant source of air pollution in California is from traffic emissions ([@c10]). We hypothesized that proximity to road traffic volumes and traffic density would be associated with increased mortality in patients undergoing TB treatment and that the effects would be mediated through clinical markers of TB severity. To test these hypotheses, we designed and implemented a large cohort study of TB patients reported to the State of California and followed longitudinally by California Department of Public Health TB clinics throughout their TB treatment.

Methods {#s2}
=======

Study Cohort {#s2.1}
------------

All reported pediatric and adult TB cases in California between 1 January 2000 and 31 December 2012 were eligible for inclusion. A TB case was specified as a person of any age with clinically diagnosed or microbiologically confirmed (or both) active TB as defined by the Centers for Disease Control and Prevention (CDC). Clinical diagnostic criteria included symptoms, physical exam, and radiographic findings consistent with TB along with an appropriate response to treatment. Acceptable microbiologic confirmation included culture or nucleic acid amplification testing (or both) positive for *Mycobacterium tuberculosis* (*Mtb*). Patients were excluded from survival analyses if traffic data were unavailable at residential addresses, if residential addresses were either not available or not geocodable to street-level resolution, if patients died or moved out of California before treatment was initiated, or if treatment dates were unavailable.

Traffic Exposure Assessment {#s2.2}
---------------------------

Residential street addresses were obtained at the time of TB diagnosis and were later transformed into geocoded coordinates using browser-based geocoding software developed by the California Environmental Health Tracking Program (CEHTP) at the California Department of Public Health (CDPH). This software matched addresses to geographic coordinates using Tele Atlas® (TomTom Telematics), Navteq® (Nokia Here), and TIGER® (U.S. Census Bureau) reference data sets for 2010 and 2011. For homeless patients, we used the shelter address or the street intersection of the patient's most recent sleeping location. Geocoding accuracy was quantified using a score based on how well the input address text elements matched the same elements of the geocoding reference database. The score ranged from 0 to 100, with 100 representing an exact match.

Traffic data from 2004 were obtained from the California Department of Transportation (Caltrans) Highway Performance Monitoring System, with data available for roads functionally classified as collectors, arterials, freeways, expressways, and interstates, collectively referred to as "major" roads in this study. Traffic data were not available for small local roads. Because the distance from traffic source for maximum health impact was uncertain ([@c41]), we calculated traffic exposures within four circular zones (buffers) of radius $100–400\; m$ around each participant's residential address using CEHTP Traffic Spatial Linkage Service software (CDPH). Within each of these buffers, we evaluated traffic volume \[average number of vehicles (vh) traversing a road segment per 24 h\] at the nearest major road and at the highest-trafficked road, and traffic density was calculated as the sum of length-adjusted major road segment traffic counts within each buffer per hour (vehicle·kilometers/hour). We selected these traffic indicators to best characterize distance to exposure source as well as peak and overall exposure concentrations. Left-censored traffic data due to the absence of major roads in a buffer were considered missing.

Outcome Assessment {#s2.3}
------------------

Patients were followed longitudinally throughout TB treatment by one of 61 local health department TB programs. Baseline and follow-up demographic, socioeconomic, and clinical data were recorded by trained local health officials into the Report of Verified Case of Tuberculosis (RVCT), a CDC-developed data collection tool. RVCT data were then entered into a CDPH central data repository (the California TB Registry). Our preselected primary outcome was all-cause mortality during active TB treatment. Follow-up time began on the first day of TB treatment and ended on the date of death (event) or was right-censored on the date of adequate completion of TB therapy, cessation of therapy for other reasons, moving out of state, loss to follow-up, or the end of the study, whichever occurred first.

Ethics Approval {#s2.4}
---------------

The study was approved by the institutional review boards at the University of California, San Francisco and the California Health and Human Services Agency Committee for the Protection of Human Subjects. Informed consent was not required because the study relied on existing public health records rather than on direct patient contact, and all personal identifiers were removed from the database before analysis.

Statistical analysis {#s2.5}
--------------------

We fit Cox proportional hazards models to determine HRs for mortality during TB treatment predicted by each traffic metric in $100 - \text{to}\, 400 - m$ buffers around residential addresses. We transformed traffic volumes and traffic density into quintiles to better adhere to log-linearity of hazard function assumptions, and we tested for linear trends across quintiles using Wald tests ([@c49]), reporting calculated *p*-values as *p*-trends. Traffic exposure associations with mortality were considered statistically significant for *p*-trends $< 0.05$ in at least two of the four buffers tested. In forming quintiles, we chose exposure cut points that would split participants into five equal groups. Individual-level demographic, socioeconomic, and clinical covariates were selected *a priori* as potential confounders and were included in the final multivariable models if associated with mortality in univariate Cox models with a *p*-value $< 0.2$. In alternative models, we additionally adjusted for two group-level variables: census block group median annual household income from the 2006--2010 American Community Survey ([@c48]) and census-tract tobacco smoking prevalence estimates ([@c37]). We tested for effect modification by defining interaction terms between traffic density and each of the following: age, sex, race, ethnicity, region of residence, enrollment year, bacteriologic confirmation, directly observed TB treatment (DOT), census-tract tobacco smoking estimates, and HIV; we fitted separate multivariable Cox models with each of these interaction terms and reported effect modification for a *p*-interaction $\leq 0.05$ in at least one buffer and a consistent pattern of effect modification in all buffers. We performed mediation analyses to determine if the effects of traffic on mortality were mediated through TB severity, and we performed multiple sensitivity analyses to test the robustness of our findings across alternative Cox models. Standard diagnostics and assumption checks were performed on all models. Time-varying covariate models were not employed; instead, covariates with time dependency were assigned fixed measurement times and values. The comorbidities diabetes, end-stage renal disease, and non-HIV immunosuppression were reported only from 2010--2012. In subgroup analyses including these comorbidities, we transformed traffic exposures into dichotomous rather than five-level categorical variables as in the other analyses owing to the small number of deaths in each subgroup. We evaluated the effects of nearest-road traffic volumes on secondary outcomes including culture conversion and successful treatment completion using unadjusted Kaplan--Meier survival analyses and testing for statistical significance between fifth- and first-quintile exposures using log-rank tests. Statistical analyses were performed using Stata/SE 13.1 (StataCorp).

Results {#s3}
=======

Of 36,511 patients with active TB reported to the State of California, we excluded 2,558 patients (7.0%) for whom we were unable to perform geocoding and traffic linkage with street-level accuracy ([Figure 1](#f1){ref-type="fig"}). We excluded an additional 1,078 patients (3.0%) who moved from California, died before treatment was initiated, or for whom treatment records were incomplete. Our final cohort of 32,875 patients with active TB contributed 22,576 person-years at risk {median follow-up of 224 d \[interquartile range (IQR) 184--293\] per patient}. There were 2,305 deaths during follow-up for a crude mortality rate of 1,021 deaths per 10,000 person-years. Most right-censored events were due to either treatment completion or moving out of California, and only 2.8% were lost to follow-up or had unspecified outcomes. Sixty percent of included patients were male, 44% were Asian, 38% were Hispanic, 77% were foreign-born, and 5% were HIV-infected ([Table 1](#t1){ref-type="table"}). Socioeconomic hardship was evident, with 53% unemployed, 5.8% homeless, and 13% using recreational drugs, excess alcohol, or both within the year before enrollment. Pulmonary TB was diagnosed in 80% of participants (24% of these cases were cavitary), extrapulmonary TB was diagnosed in 29% of participants, and 79% of TB cases were microbiologically confirmed. Patients living in high-traffic-density neighborhoods were younger and more likely to be male, Asian, black, foreign-born, a recent immigrant, from southern California or the San Francisco Bay Area, living within the city limits, living in more densely populated and lower-income block groups, unemployed, homeless, a recreational drug/excess alcohol user, and HIV-infected compared with those with low traffic density exposure. A number of covariates were associated with increased mortality during TB treatment in unadjusted analysis, including being unemployed, having both pulmonary and extrapulmonary TB, having TB meningitis, having miliary TB, having microbiologically confirmed TB, and having the following comorbidities: diabetes, HIV, non-HIV immunosuppression, and end-stage renal disease (see Table S1).

![Study flow chart. TB, tuberculosis.](EHP1699_f1){#f1}

###### 

Characteristics by traffic density, $n = 32,875$.

Table 1 lists characteristics in the first column; the corresponding values of low traffic density (percentage) (n equals 16417), high traffic density (percentage) (n equals 16458), and p values are listed in the other columns.

  Characteristic                                                                                                    Traffic density, $n$ (%)[^*a*^](#t1n1){ref-type="table-fn"}                             
  ----------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------- ------------------------- -----------
  Age at diagnosis, median (IQR), y                                                                                 47.7 (30.8--64.5)                                             46.2 (30.5--62.2)         $< 0.001$
  Male sex                                                                                                          9,570 (58.3)                                                  10,012 (60.8)             $< 0.001$
  Race and ethnicity                                                                                                                                                                                        $< 0.001$
    Asian                                                                                                           7,058 (43.0)                                                  7,252 (44.1)               
    Hispanic                                                                                                        6,525 (39.8)                                                  6,075 (36.9)               
    White, non-Hispanic                                                                                             1,559 (9.50)                                                  1,452 (8.82)               
    Black, non-Hispanic                                                                                             1,100 (6.70)                                                  1,508 (9.16)               
    Native American/Alaskan or Pacific Islander                                                                     144 (0.88)                                                    137 (0.83)                 
    Unknown                                                                                                         31 (0.19)                                                     34 (0.21)                  
  Foreign born                                                                                                      12,442/16,362 (76.0)                                          12,731/16,419 (77.5)      0.001
  Recent immigrant                                                                                                  3,852/16,362 (23.5)                                           4,175/16,419 (25.4)       $< 0.001$
  Region                                                                                                                                                                                                    $< 0.001$
    Southern California                                                                                             8,840 (53.9)                                                  9,722 (59.1)               
    Central Valley                                                                                                  3,106 (18.9)                                                  1,279 (7.77)               
    North Coast and Mountain                                                                                        393 (2.39)                                                    172 (1.05)                 
    San Francisco Bay Area                                                                                          3,159 (19.2)                                                  4,760 (28.9)               
    Central Coast                                                                                                   919 (5.60)                                                    525 (3.19)                 
  Residence within the city limits                                                                                  15,823/16,376 (96.6)                                          16,306/16,440 (99.2)      $< 0.001$
  Population density, $\text{mean} \pm \text{SD}$, ${\text{persons}/{km}}^{2}$[^*c*^](#t1n3){ref-type="table-fn"}   $4,196 \pm 3,452$                                             $7,144 \pm 7,779$         $< 0.001$
  Median annual household income, median (IQR), USD[^*c*^](#t1n3){ref-type="table-fn"}                              53,832 (38,230--74,836)                                       45,722 (31,680--65,214)   $< 0.001$
  Estimated census tract percent smoking prevalence, $\text{mean} \pm \text{SD}$                                    $14.9 \pm 5.11$                                               $14.1 \pm 5.46$           $< 0.001$
  Unemployed                                                                                                        8,124/15,824 (51.3)                                           8,680/16,082 (54.0)       $< 0.001$
  Homeless                                                                                                          568/16,339 (3.48)                                             1,325/16,375 (8.09)       $< 0.001$
  Substance abuse[^*d*^](#t1n4){ref-type="table-fn"}                                                                1,776/16,193 (11.0)                                           2,370/16,263 (14.6)       $< 0.001$
  HIV-infected                                                                                                      648 (3.95)                                                    985 (5.98)                $< 0.001$
  Microbiologically confirmed TB                                                                                    12,868/16,409 (78.4)                                          12,995/16,451 (79.0)      0.21
  Pulmonary TB                                                                                                      13,050 (79.5)                                                 13,146 (79.9)             0.39
  Extrapulmonary TB                                                                                                 4,754 (29.0)                                                  4,886 (29.7)              0.15
  Cavitary TB                                                                                                       3,221/16,399 (19.6)                                           3,145/16,443 (19.1)       0.24
  Miliary TB                                                                                                        279 (1.70)                                                    287 (1.74)                0.76
  MDR-TB                                                                                                            194/12,664 (1.53)                                             180/12,891 (1.40)         0.37
  Treatment                                                                                                         $n = 16,316$                                                  $n = 16,358$              $< 0.001$
    Self-administered for all doses                                                                                 2,857 (17.5)                                                  3,020 (18.5)               
    DOT for all doses                                                                                               8,856 (54.3)                                                  10,145 (62.0)              
    DOT and self-administered doses                                                                                 4,603 (28.2)                                                  3,193 (19.5)               
  Days to culture conversion, median (IQR)                                                                          53 (32--78)                                                   53 (33--80)               0.33
  Treatment duration,[^*e*^](#t1n5){ref-type="table-fn"} median (IQR), days                                         244 (188--301)                                                248 (190--302)            0.37

Note: DOT, directly observed tuberculosis (TB) treatment; IQR, interquartile range; MDR-TB, multidrug-resistant TB, resistant to both isoniazid and rifampicin; SD, standard deviation; USD, U.S. dollars.

Traffic density is defined as the sum of length-adjusted road segment traffic volumes in the $400 - m$ buffer around residential addresses, using the median value of $1,525\,\text{vh} \cdot {km}/h$ as the low-high cutoff. Column values represent "Number (%)" unless indicated otherwise.

The denominator is 16,417 for low traffic density and 16,458 for high traffic density unless otherwise indicated.

Obtained from American Census Survey 2006-2010 census block group data ([@c48]).

Excess alcohol and/or recreational drug use (oral, inhaled, or injected) within one year before TB diagnosis.

Treatment duration among those who completed treatment.

Median (IQR) traffic volumes (vehicles/day) were 12,610 (5,000--24,800) vh/d at the nearest major road and 29,000 (17,600--45,000) vh/d at the highest-trafficked road in the $400 - m$ buffer ([Table 2](#t2){ref-type="table"}). Median (IQR) traffic densities (vehicles·kilometer/hour) in the $100 - \text{to}\, 400 - m$ buffers were 106 (39.6--230), 356 (138--746), 820 (337--1,647), and 1,525 (690--3,009) vh·km/h, respectively. In sensitivity analyses, excluded patients were similar to included patients with the following exceptions: Those excluded were more likely to reside outside the city limits \[257/3,608 (7.1%) vs. 687/32,816 (2.09%)\], in lower population density census block groups \[$\text{mean} \pm \text{standard}\,\text{deviation}$ (SD) $2,979 \pm 4,656{\,\text{persons}/{km}}^{2}$ vs. $5,672 \pm 6,198{\,\text{persons}/{km}}^{2}$\], in less traffic-dense neighborhoods \[$1,066 \pm 2,724\,\text{vh} \cdot {km}/h$ in the $400 - m$ buffer vs. $2,977 \pm 4,193\,\text{vh} \cdot {km}/h$\], in the Central Valley \[800/3,636 (22%) vs. 4,385/32,875 (13%)\], and in higher income census block groups \[$69,467 \pm 35,039\,\text{USD}$ vs. $55,284 \pm 28,847\,\text{USD}$\]. Geocoding accuracy was slightly higher for patients enrolled between 2010 and 2011 (geocoding score of $95 \pm 14$) than for those enrolled in other years of the study (geocoding score of $93 \pm 19$; $p < 0.001$). Patients reported with TB between 2010 and 2011 were less likely to be excluded because of an inability to geocode the residential address \[$n = 30/4,697$ (0.63%)\] than those reported with TB in other years of the study \[$n = 706/31,079$ (2.2%)\].

###### 

Traffic statistics by buffer and quintile.

Table 2 lists exposure in the first column; the corresponding n values, mean, median, IQR, minimum, and maximum are listed in the other columns.

  Exposure                                                                $n$      Mean      Median           IQR         Minimum   Maximum
  ----------------------------------------------------------------------- -------- --------- --------- ------------------ --------- ---------
  Traffic volumes of nearest road ($\text{vh}/24\,\text{h}$)                                                                         
   $100 - m$ buffer                                                                                                                  
    Q1                                                                    3,866    2,077     2,082        1,210--2,830    32        3,900
    Q2                                                                    3,815    6,087     5,960        4,940--7,290    3,906     8,680
    Q3                                                                    3,865    12,242    12,000      10,245--14,100   8,686     16,500
    Q4                                                                    3,815    21,283    21,314      18,700--23,650   16,521    26,500
    Q5                                                                    3,830    54,292    35,056      30,000--45,000   26,508    382,000
    All                                                                   19,191   19,160    12,000      4,940--23,600    32        382,000
   $200 - m$ buffer                                                                                                                  
    Q1                                                                    5,621    2,110     2,110        1,210--2,910    32        3,950
    Q2                                                                    5,573    6,212     6,060        5,000--7,410    3,956     8,930
    Q3                                                                    5,622    12,595    12,475      10,500--14,450   8,938     16,827
    Q4                                                                    5,580    21,971    22,000      19,400--24,473   16,840    27,700
    Q5                                                                    5,573    60,158    36,929      30,795--48,200   27,725    382,000
    All                                                                   27,969   20,563    12,400      5,000--24,400    32        382,000
   $300 - m$ buffer                                                                                                                  
    Q1                                                                    6,212    2,119     2,130        1,210--2,920    32        3,960
    Q2                                                                    6,246    6,249     6,100        5,000--7,500    3,961     9,000
    Q3                                                                    6,246    12,785    12,646      10,700--14,700   9,010     17,000
    Q4                                                                    6,157    22,227    22,285      19,700--24,700   17,004    27,879
    Q5                                                                    6,201    61,321    37,208      31,000--49,275   27,887    382,000
    All                                                                   31,062   20,898    12,600      5,000--24,700    32        382,000
   $400 - m$ buffer                                                                                                                  
    Q1                                                                    6,523    2,134     2,130        1,210--2,990    32        4,000
    Q2                                                                    6,434    6,283     6,126        5,000--7,500    4,001     9,030
    Q3                                                                    6,486    12,799    12,673      10,702--14,700   9,035     17,000
    Q4                                                                    6,457    22,272    22,300      19,700--14,800   17,004    27,900
    Q5                                                                    6,463    61,578    37,300      31,246--49,700   27,903    382,000
    All                                                                   32,363   20,985    12,610      5,000--24,800    32        382,000
  Traffic volumes of highest-trafficked road ($\text{vh}/24\,\text{h}$)                                                              
   $100 - m$ buffer                                                                                                                  
    Q1                                                                    3,912    2,682     2,600        1,481--3,860    32        5,000
    Q2                                                                    3,821    8,080     7,960        6,470--9,610    5,020     11,500
    Q3                                                                    3,856    15,748    15,700      13,600--17,700   11,530    20,300
    Q4                                                                    3,951    25,099    24,789      22,600--27,740   20,301    30,300
    Q5                                                                    3,758    74,191    41,853      35,000--61,000   30,358    382,000
    All                                                                   19,298   24,876    15,700      6,390--27,500    32        382,000
   $200 - m$ buffer                                                                                                                  
    Q1                                                                    5,684    3,956     3,958        2,290--5,600    32        7,500
    Q2                                                                    5,701    11,842    11,900      9,500--14,089    7,503     16,500
    Q3                                                                    5,642    20,969    21,100      18,800--23,300   16,504    25,200
    Q4                                                                    5,643    30,623    30,000      27,725--33,400   25,231    37,800
    Q5                                                                    5,651    106,348   54,600     42,500--164,000   37,839    382,000
    All                                                                   28,321   34,677    21,000      9,480--33,300    32        382,000
   $300 - m$ buffer                                                                                                                  
    Q1                                                                    6,286    5,633     5,500        3,260--8,000    32        10,809
    Q2                                                                    6,322    16,253    16,400      13,666--18,841   10,810    21,300
    Q3                                                                    6,332    25,612    25,600      23,450--27,700   21,303    29,865
    Q4                                                                    6,260    35,908    35,540      32,356--39,400   29,892    44,004
    Q5                                                                    6,308    138,578   124,000    52,718--210,000   44,012    382,000
    All                                                                   31,508   44,410    25,600      13,700--39,400   32        382,000
   $400 - m$ buffer                                                                                                                  
    Q1                                                                    6,566    7,929     7,890       4,530--11,690    59        14,600
    Q2                                                                    6,607    20,247    20,499      17,600--22,806   14,623    25,000
    Q3                                                                    6,639    29,249    29,120      27,142--31,269   25,009    34,000
    Q4                                                                    6,514    41,116    40,333      37,208--45,300   34,022    52,000
    Q5                                                                    6,549    168,797   165,000    100,000--229,000  52,200    382,000
    All                                                                   32,875   53,332    29,000      17,600--45,000   32        382,000
  Traffic density ($\text{vh} \cdot {km/h}$)                                                                                         
   $100 - m$ buffer                                                                                                                  
    Q1                                                                    3,861    15.3      14.8          8.33--14.8     0.008     30.6
    Q2                                                                    3,860    51.1      49.8          39.6--62.7     30.6      74.8
    Q3                                                                    3,878    107       106           88.8--125      74.8      146
    Q4                                                                    3,852    204       200            172--230      146       276
    Q5                                                                    3,847    704       419            333--633      277       8,998
    All                                                                   19,298   216       106           39.6--230      0.008     8,998
   $200 - m$ buffer                                                                                                                  
    Q1                                                                    5,656    51.4      50.6          26.5--75.4     0.004     104
    Q2                                                                    5,675    175       173            138--211      104       256
    Q3                                                                    5,689    361       356            305--413      256       477
    Q4                                                                    5,659    657       646            553--749      477       905
    Q5                                                                    5,642    2,594     1,496        1,109--3,335    905       22,020
    All                                                                   28,321   766       356            138--746      0.004     22,020
   $300 - m$ buffer                                                                                                                  
    Q1                                                                    6,266    126       123           61.5--190      0.17      262
    Q2                                                                    6,316    425       423            335--507      262       610
    Q3                                                                    6,328    829       819            711--947      610       1,087
    Q4                                                                    6,318    1,453     1,416        1,241--1,650    1,087     1,964
    Q5                                                                    6,280    5,532     3,939        2,533--7,614    1,964     34,642
    All                                                                   31,508   1,671     820           337--1,647     0.17      34,642
   $400 - m$ buffer                                                                                                                  
    Q1                                                                    6,547    266       263            127--402      0.09      542
    Q2                                                                    6,578    837       827            687--988      542       1,159
    Q3                                                                    6,590    1,533     1,522        1,334--1,729    1,160     1,954
    Q4                                                                    6,581    2,649     2,547        2,233--3,008    1,955     3,759
    Q5                                                                    6,579    9,590     8,226       5,098--12,449    3,760     48,305
    All                                                                   32,875   2,977     1,525         690--3,009     0.09      48,305

Note: IQR, interquartile range; Q1--Q5, quintiles 1 through 5, where Q5 is the highest quintile of traffic exposure; vh, vehicle.

Traffic volumes and traffic densities were associated with increased mortality during TB treatment, with statistically significant *p*-trends for increasing HRs across quintiles for the majority of the 12 scenarios tested ([Table 3](#t3){ref-type="table"}; see also Table S1). For instance, participants exposed to the second quintile of nearest-road traffic volumes within the $100 - m$ buffer had a 3% increased risk of death compared with those exposed to lowest-quintile traffic volumes \[$\text{HR} = 1.03$ (95% CI: 0.86, 1.25)\] ([Figure 2](#f2){ref-type="fig"}). This risk increased incrementally to a 28% risk of death for the highest quintile of traffic volume exposure \[$\text{HR} = 1.28$ (95% CI: 1.07, 1.53)\], a trend that was statistically significant ($p - \text{trend} = 0.002$) ([Figure 2](#f2){ref-type="fig"}). Furthermore, as the buffer size decreased, fifth-quintile mortality hazards increased, and trends across quintiles became more statistically significant. For example, although the highest-trafficked road in the $400 - m$ buffer was associated with increased mortality, the fifth-quintile HR was only 1.10 (95% CI: 0.95, 1.27), and there was not a significant trend for increasing mortality across quintiles. In contrast, fifth-quintile traffic volumes of the highest-trafficked road in the $100 - m$ buffer were associated with a 29% increased hazard of death \[$\text{HR} = 1.29$ (95% CI: 1.07, 1.55)\], with a significant trend across traffic exposure quintiles ($p - \text{trend} < 0.001$).

![Cumulative hazards of death by nearest-road traffic volume quintiles in $100 - m$ buffers around residential addresses. Adjusted for age, sex, race, ethnicity, foreign birth, recent immigration within 5 y before tuberculosis (TB) diagnosis, population density, unemployment within one year before TB diagnosis, homelessness within one year before TB diagnosis, excess alcohol and/or recreational drug use within one year before TB diagnosis, and HIV infection. CI, confidence interval; HR, hazard ratio.](EHP1699_f2){#f2}

###### 

Adjusted mortality hazard ratios (95% confidence intervals) for traffic metrics in $100–400 - m$ buffers around residential addresses.

Table 3 lists exposure in the first column; the corresponding values of 100, 200, 300, and 400 meter buffers are listed in the other columns separately.

  Exposure                                                                $100 - m$ buffer    $200 - m$ buffer    $300 - m$ buffer    $400 - m$ buffer
  ----------------------------------------------------------------------- ------------------- ------------------- ------------------- -------------------
  Traffic volumes of nearest road ($\text{vh}/24\,\text{h}$)                                                                           
   $n$                                                                    18,396              26,814              29,753              30,985
   Q1 (HR)                                                                1.00                1.00                1.00                1.00
   Q2 \[HR (95%CI)\]                                                      1.03 (0.86, 1.25)   1.02 (0.87, 1.18)   1.01 (0.87, 1.17)   0.99 (0.85, 1.14)
   Q3 \[HR (95%CI)\]                                                      1.14 (0.95, 1.37)   1.13 (0.98, 1.32)   1.12 (0.97, 1.29)   1.10 (0.96, 1.26)
   Q4 \[HR (95%CI)\]                                                      1.19 (0.99, 1.43)   1.19 (1.03, 1.39)   1.20 (1.04, 1.38)   1.15 (1.00, 1.33)
   Q5 \[HR (95%CI)\]                                                      1.28 (1.07, 1.53)   1.19 (1.02, 1.38)   1.15 (1.00, 1.33)   1.13 (0.98, 1.30)
   *p*-Trend                                                              0.002               0.004               0.006               0.01
  Traffic volumes of highest-trafficked road ($\text{vh}/24\,\text{h}$)                                                                
   $n$                                                                    18,500              27,156              30,185              31,480
   Q1 (HR)                                                                1.00                1.00                1.00                1.00
   Q2 \[HR (95%CI)\]                                                      1.07 (0.88, 1.29)   1.22 (1.05, 1.42)   1.22 (1.06, 1.41)   1.21 (1.05, 1.40)
   Q3 \[HR (95%CI)\]                                                      1.29 (1.08, 1.55)   1.29 (1.10, 1.50)   1.30 (1.12, 1.50)   1.11 (0.96, 1.28)
   Q4 \[HR (95%CI)\]                                                      1.29 (1.07, 1.54)   1.32 (1.14, 1.54)   1.22 (1.05, 1.42)   1.14 (0.98, 1.32)
   Q5 \[HR (95%CI)\]                                                      1.29 (1.07, 1.55)   1.24 (1.06, 1.45)   1.15 (0.99, 1.34)   1.10 (0.95, 1.27)
   *p*-Trend                                                              $< 0.001$           0.005               0.10                0.46
  Traffic density ($\text{vh} \cdot {km/h}$)                                                                                           
   $n$                                                                    18,500              27,156              30,185              31,480
   Q1 (HR)                                                                1.00                1.00                1.00                1.00
   Q2 \[HR (95%CI)\]                                                      1.02 (0.85, 1.23)   1.25 (1.08, 1.46)   1.11 (0.96, 1.29)   1.07 (0.93, 1.24)
   Q3 \[HR (95%CI)\]                                                      1.07 (0.89, 1.29)   1.25 (1.08, 1.46)   1.30 (1.12, 1.49)   1.23 (1.07, 1.42)
   Q4 \[HR (95%CI)\]                                                      1.33 (1.12, 1.59)   1.31 (1.13, 1.52)   1.17 (1.01, 1.36)   1.12 (0.97, 1.30)
   Q5 \[HR (95%CI)\]                                                      1.18 (0.98, 1.41)   1.17 (1.00, 1.37)   1.13 (0.97, 1.31)   1.06 (0.91, 1.23)
   *p*-Trend                                                              0.005               0.04                0.09                0.36

Note: CI, confidence interval; HR, hazard ratio; *p*-trend, the *p*-value for the trend across quintiles of traffic exposure. Q1-Q5, quintiles 1 through 5, where Q5 is the highest quintile of traffic exposure; vh, vehicle. Adjusted for age, sex, race, ethnicity, foreign birth, recent immigration within 5 y before tuberculosis (TB) diagnosis, population density, region of residence, unemployment within 1 y before TB diagnosis, homeless within one year before TB diagnosis, excess alcohol and/or recreational drug use within one year before TB diagnosis, and HIV infection.

Among potential confounders, age and recent immigration augmented mortality hazards, whereas sex, employment status, HIV status, population density, and excess alcohol and/or recreational drug use attenuated mortality hazards. In alternative Cox models, we adjusted for group-level covariates in addition to individual-level covariates ([Table 4](#t4){ref-type="table"}) and found that the addition of census block group household income did not attenuate HRs. In contrast, adjusting for census-tract smoking estimates augmented mortality hazards such that exposure to the highest quintile (Q5) of nearest-road traffic volumes in the $100 - m$ buffer was associated with a 41% increased risk of death during TB treatment \[$\text{HR} = 1.41$ (95% CI: 1.16, 1.75)\] compared with lowest-quintile (Q1) traffic volume exposures. In additional alternative Cox models, the findings did not change significantly with exclusion of cases that were not microbiologically confirmed or with exclusion of patients who lived at multiple addresses during treatment.

###### 

Adjusted mortality hazard ratios (95% confidence intervals) for alternative Cox models using nearest-road traffic volume exposures, $100 - m$ buffer.

Table 4 lists exposure in the first column. The corresponding values of Cox model with only individual-level covariates, add group-level household income to adjusted model, add group-level smoking estimates to adjusted model, exclude nonmicrobiologically confirmed cases, exclude patients who moved within California, left-censored values: assign zero instead of missing for the Alternative Cox model are listed in the other columns.

  Exposure: Traffic volumes of nearest road ($\text{vh}/24\,\text{h}$)   Alternative Cox model                                                                                   
  ---------------------------------------------------------------------- ----------------------- ------------------- ------------------- ------------------- ------------------- -------------------
  $n$                                                                    18,396                  18,375              14,478              14,404              17,480              32,832
  Q1 (HR)                                                                1.00                    1.00                1.00                1.00                1.00                1.00
  Q2 \[HR (95% CI)\]                                                     1.03 (0.86, 1.25)       1.03 (0.86, 1.24)   1.13 (0.91, 1.40)   1.05 (0.87, 1.28)   1.05 (0.87, 1.27)   1.00
  Q3 \[HR (95% CI)\]                                                     1.14 (0.95, 1.37)       1.14 (0.95, 1.36)   1.23 (1.00, 1.52)   1.16 (0.96, 1.40)   1.16 (0.96, 1.40)   0.90 (0.79, 1.02)
  Q4 \[HR (95% CI)\]                                                     1.19 (0.99, 1.43)       1.19 (0.99, 1.43)   1.29 (1.05, 1.59)   1.20 (1.00, 1.46)   1.21 (1.01, 1.46)   1.01 (0.90, 1.14)
  Q5 \[HR (95% CI)\]                                                     1.28 (1.07, 1.53)       1.27 (1.06, 1.52)   1.41 (1.16, 1.75)   1.28 (1.06, 1.54)   1.28 (1.07, 1.54)   1.10 (0.98, 1.23)
  *p*-Trend                                                              0.002                   0.003               $< 0.001$           0.004               0.002               0.04

Note: CI, confidence interval; HR, hazard ratio; *p*-Trend, the *p*-value for the trend across quintiles of traffic exposure; Q1--Q5, quintiles 1 through 5, where Q5 is the highest quintile of traffic exposure; vh, vehicle.

Adjusted for individual-level covariates: age, sex, race, ethnicity, foreign birth, recent immigration within 5 y prior to tuberculosis (TB) diagnosis, population density, region of residence, unemployment within one year before TB diagnosis, homeless within one year before TB diagnosis, excess recreational drug and/or alcohol use within one year before TB diagnosis, and HIV infection.

Group-level covariate: census block group median annual household income.

Group-level covariate: census tract smoking prevalence estimates.

Region of residence, directly observed therapy, and census-tract smoking prevalence modified the effects of traffic exposure on mortality ([Table 5](#t5){ref-type="table"}). For instance, those exposed to the highest quintile of traffic density in the $100 - m$ buffer had an 88% increased mortality hazard in the Central Valley and a 19% increased mortality hazard in southern California, but no increased hazard in the San Francisco Bay Area ($p - \text{interaction} = 0.03$). Those who self-administered some or all of their TB medication experienced an increased traffic mortality hazard compared with those who received only directly observed therapy, and traffic mortality hazards were smaller for TB patients living in high-smoking census tracts compared with those living in low-smoking census tracts. Additionally, traffic effects were slightly higher in most buffers for patients $> 65\; y$ old, in patients enrolled from 2004--2009, and in patients with diabetes ([Table 5](#t5){ref-type="table"}; see also Table S2); traffic effects were slightly lower for those with HIV and other forms of immunosuppression, but these interactions did not reach statistical significance except for other forms of immunosuppression in the $100 - m$ buffer. We tested multidrug-resistant (MDR) TB and cavitation as possible confounders. Although both types of TB were associated with mortality (see Table S1), adjusting for these variables did not significantly change HRs in multivariable analyses (see Table S4). In addition, we tested both variables as potential effect modifiers in the association between traffic density and mortality and did not find statistically significant interactions in any of the buffers (see Table S5). In mediation analyses, the effects of traffic exposure on mortality did not appear to be mediated through TB severity. Although surrogates for TB severity (smear positivity, having both pulmonary and extrapulmonary TB, TB meningitis, and miliary TB) were all significantly associated with increased mortality (see Table S1), traffic exposures were not statistically significantly associated with TB severity, and the addition of TB severity variables into Cox models did not attenuate mortality HRs. We also evaluated diabetes and end-stage renal disease as intermediaries on the causal pathway from TRAP exposure to mortality during TB treatment and found that although each comorbidity was associated with increased mortality (see Table S1), we did not find a statistically significant association between traffic density and increased risk for diabetes or end-stage renal disease.

In Kaplan--Meier survival analyses, the median time to culture conversion was 54 d (IQR, 32--83), and the median time to successful completion of treatment was 256 d (IQR, 190--309); these times did not differ significantly between lowest- and highest-quintile nearest-road traffic volumes in the $100 - m$ buffer (see Table S3, Figure S1, and Figure S2). The 2-month culture conversion rates were 56% overall, 55% for patients exposed to lowest-quintile nearest-traffic volumes (in the $100 - m$ buffer), and 57% for those exposed to highest-quintile traffic. The 9-month successful treatment completion rates were 54% overall, 55% for patients exposed to lowest-quintile traffic, and 53% for patients living near the highest-quintile traffic volumes.

###### 

Adjusted mortality hazard ratios (95% confidence intervals) for highest quintile traffic density in each buffer, stratified by effect modifier.

Table 5 lists population characteristics in the first column; the corresponding n values and values of 100, 200, 300, 400 meter buffers are listed in the other columns separately.

  Population                $n$      $100 - m$ buffer \[HR (95% CI)\]                      $200 - m$ buffer \[HR (95% CI)\]                      $300 - m$ buffer \[HR (95% CI)\]                      $400 - m$ buffer \[HR (95% CI)\]
  ------------------------- -------- ----------------------------------------------------- ----------------------------------------------------- ----------------------------------------------------- -----------------------------------------------------
  Entire cohort             31,480   1.18 (0.98, 1.41)[^\*^](#t5n1){ref-type="table-fn"}   1.17 (1.00, 1.37)[^\*^](#t5n1){ref-type="table-fn"}   1.13 (0.97, 1.31)                                     1.06 (0.91, 1.23)
  Region                                                                                                                                                                                                
   San Francisco Bay Area   7,731    0.88 (0.61, 1.26)                                     0.99 (0.73, 1.36)                                     1.18 (0.87, 1.61)                                     0.93 (0.69, 1.25)
   Central Valley           3,902    1.88 (1.09, 3.24)[^\*^](#t5n1){ref-type="table-fn"}   1.78 (1.12, 2.84)[^\*^](#t5n1){ref-type="table-fn"}   1.53 (1.02, 2.31)                                     1.27 (0.87, 1.87)
   Southern California      17,935   1.19 (0.94, 1.50)[^\*^](#t5n1){ref-type="table-fn"}   1.13 (0.92, 1.39)                                     1.04 (0.85, 1.26)                                     1.07 (0.87, 1.30)
   *p*-Interaction          ---      0.03                                                  0.19                                                  0.52                                                  0.85
  Exclusive DOT                                                                                                                                                                                         
   No                       13,098   1.21 (0.86, 1.70)[^\*^](#t5n1){ref-type="table-fn"}   1.35 (1.00, 1.82)[^\*^](#t5n1){ref-type="table-fn"}   1.47 (1.10, 1.96)[^\*^](#t5n1){ref-type="table-fn"}   1.39 (1.06, 1.83)[^\*^](#t5n1){ref-type="table-fn"}
   Yes                      18,207   1.12 (0.91, 1.40)                                     1.03 (0.86, 1.24)                                     0.93 (0.78, 1.12)                                     0.85 (0.71, 1.01)
   *p*-Interaction          ---      0.21                                                  0.29                                                  0.01                                                  0.005
  Smoking prevalence                                                                                                                                                                                    
   Low                      12,861   1.38 (1.04, 1.84)[^\*^](#t5n1){ref-type="table-fn"}   1.48 (1.16, 1.89)[^\*^](#t5n1){ref-type="table-fn"}   1.41 (1.11, 1.79)[^\*^](#t5n1){ref-type="table-fn"}   1.28 (1.01, 1.62)[^\*^](#t5n1){ref-type="table-fn"}
   High                     12,241   1.14 (0.83, 1.55)                                     1.12 (0.86, 1.44)                                     1.03 (0.81, 1.31)                                     0.93 (0.73, 1.17)
   *p*-Interaction          ---      0.40                                                  0.003                                                 0.08                                                  0.32
  Age, y                                                                                                                                                                                                
   0--64                    24,154   1.05 (0.77, 1.41)                                     1.11 (0.91, 1.53)                                     0.94 (0.73, 1.21)                                     0.87 (0.68, 1.11)
   $\geq 65$                7,326    1.24 (0.98, 1.55)[^\*^](#t5n1){ref-type="table-fn"}   1.17 (0.96, 1.42)                                     1.19 (0.99, 1.43)[^\*^](#t5n1){ref-type="table-fn"}   1.14 (0.96, 1.37)
   *p*-Interaction          ---      0.63                                                  0.84                                                  0.45                                                  0.47
  Enrollment Year                                                                                                                                                                                       
   2000--2003               11,392   1.01 (0.77, 1.34)                                     1.04 (0.81, 1.33)                                     1.05 (0.83, 1.34)                                     0.98 (0.77, 1.24)
   2004--2006               7,140    1.68 (1.14, 2.48)[^\*^](#t5n1){ref-type="table-fn"}   1.40 (1.01, 1.95)[^\*^](#t5n1){ref-type="table-fn"}   1.29 (0.94, 1.75)                                     1.01 (0.76, 1.36)
   2007--2009               6,793    0.99 (0.67, 1.46)                                     1.31 (0.95, 1.82)                                     1.37 (0.99, 1.88)                                     1.35 (0.99, 1.85)
   2010--2012               6,155    1.33 (0.83, 2.12)                                     1.05 (0.73, 1.50)                                     0.90 (0.65, 1.25)                                     1.00 (0.73, 1.38)
   *p*-Interaction          ---      0.07                                                  0.69                                                  0.84                                                  0.44
  HIV                                                                                                                                                                                                   
   No                       29,929   1.26 (1.04, 1.52)[^\*^](#t5n1){ref-type="table-fn"}   1.19 (1.01, 1.40)[^\*^](#t5n1){ref-type="table-fn"}   1.15 (0.98, 1.34)[^\*^](#t5n1){ref-type="table-fn"}   1.06 (0.91, 1.23)
   Yes                      1,551    0.60 (0.32, 1.14)                                     0.95 (0.55, 1.63)                                     0.88 (0.51, 1.51)                                     1.09 (0.59, 1.99)
   *p*-Interaction          ---      0.053                                                 0.31                                                  0.51                                                  0.74

Note: CI, confidence interval; DOT, directly observed tuberculosis (TB) treatment; HR, hazard ratio. Adjusted for age, sex, race, ethnicity, foreign birth, recent immigration within 5 y before TB diagnosis, population density, region, unemployment 1 y before TB diagnosis, homeless within one year before TB diagnosis, excess alcohol and/or recreational drug use within one year before TB diagnosis, and HIV infection. The HR represents the highest quintile traffic density compared with the lowest quintile traffic density in each effect modifier level and buffer.

A statistically significant trend ($p - \text{trend} < 0.05$) exists across quintiles.

Discussion {#s4}
==========

To our knowledge, this is the first study to investigate the effects of traffic proximity on mortality during active TB treatment in a large, longitudinally followed patient cohort. We found that patients residing in high-traffic neighborhoods in California were at increased risk of death during TB treatment compared with those residing in low-traffic neighborhoods; we also found that there were statistically significant trends of increasing mortality across increasing quintiles of traffic exposure. Our findings were robust across several analytical models and after controlling for multiple demographic, socioeconomic, and clinical variables.

Our findings are consistent with a growing body of evidence linking traffic proximity and traffic-related air pollution with all-cause, cardiopulmonary, and cancer mortality ([@c6]; [@c12], [@c13]; [@c20]; [@c26], [@c27]; [@c47]). Our study expands this evidence by focusing on a specific and potentially vulnerable cohort of patients using individual-level exposure and outcome data. Mortality during TB treatment remains high, as was evident in our study cohort and throughout the world ([@c16]; [@c17]; [@c46]). Although many factors have been implicated in these poor TB patient outcomes ([@c38]), the effects of environmental factors such as ambient air pollution have remained uncertain. Our findings provide preliminary evidence that residential proximity to traffic could be an important modifiable risk factor for poor TB outcomes, and further studies investigating the effects of specific traffic-related pollutants are needed to confirm these observations.

Traffic effects were greatest and most statistically significant in the smaller buffers around residential addresses. Our observations are consistent with roadside air quality monitoring studies, which have found progressive decay of ambient pollutant concentrations down to background levels within $300–600\; m$, with the rate of decay over distance from the road dependent on vegetation barriers, wind direction, and type of pollutant ([@c29]; [@c35]; [@c55]). However, between-buffer comparisons should be made with caution in our study. Low-traffic neighborhood roads were not measured in this analysis and likely accounted for a larger proportion of missing data in smaller buffers, thus leading to potential differential misclassification of exposure between buffers.

There was a statistically significant dose--response relationship across many of the 12 exposure scenarios tested, as indicated by $p - \text{trends} < 0.05$. However, the traffic effect on mortality typically plateaued in the third or fourth quintile and often dropped slightly in the fifth quintile. It is possible that the traffic effect on mortality is not linear but rather plateaus with higher levels of exposure. The fifth-quintile exposure level also encompassed a much larger exposure range than the other levels ([Table 2](#t2){ref-type="table"}), and this heterogeneity in exposure in the fifth quintile could have affected the results for this group.

Several interactions were evident from our analyses. Traffic effects were more pronounced in southern California and the Central Valley, where the background air quality is the poorest in the state ([@c1]), and were also greater in patients living in low-smoking-prevalence census tracts. Evidence of smoking effect modification has been observed in several ambient air pollution health effects cohort studies, with some studies reporting augmented air pollution effects in smokers and others reporting diminished effects ([@c5], [@c6]; [@c7]; [@c41]). To our knowledge, there have been no studies examining the effect modification of smoking in the association between air pollution and TB outcomes, and more research is needed in this area using individual-level data because our smoking analysis was limited by aggregate smoking estimates. Traffic mortality hazards were significantly lower in those exclusively receiving DOT for the duration of their treatment than in those who received at least some self-administered dosing, suggesting that substandard adherence to therapy may accentuate the effects of traffic exposures in patients with active TB. We are unaware of other studies that have evaluated medication adherence and air pollution interactions, and further research is needed to corroborate these findings because air pollution and medication adherence may both be important risk factors for poor treatment outcomes among vulnerable groups with respiratory disease ([@c9]). Traffic effects were slightly higher in those $\geq 65\; y\,\text{old}$ and in those with diabetes, raising concern that advanced age and certain chronic diseases could increase susceptibility to the harmful effects of air pollution. Further research is needed in these vulnerable populations.

Our observational study is hypothesis-generating for future studies. Through what biologic mechanisms did TRAP contribute to mortality in patients undergoing TB treatment? It is possible that exposure to TRAP has deleterious effects on immunologic responses to *Mtb*, a theory supported by *in vitro* and animal studies. For instance, TB-infected rats chronically exposed to diesel exhaust particles (DEP) carried a higher mycobacterial burden than nonexposed controls ([@c21]), and *Mtb*-stimulated human peripheral blood monocytes exposed to DEP demonstrated suppression of key host antimycobacterial immune responses ([@c43]).

Our study has several strengths. TB patients were followed longitudinally with demographic, clinical, treatment, and mortality data collected prospectively by trained health care providers at the time of clinic visits, decreasing the likelihood of recall bias and reporting errors. This was a large cohort study focusing on a specific disease process for the entire state of California, where TB notification rates are estimated at $> 99\%$ ([@c15]), limiting the risk for potential selection bias. Medical fees were not a significant barrier to receipt of necessary TB care, which is covered by private health insurance, Medi-Cal, and county Department of Public Health programs, thereby also reducing loss to follow-up secondary to inability to pay for treatment.

Our study also has several limitations. Exposures with time dependency, namely traffic volumes, traffic density, and residential addresses, were assigned fixed measurement times and values, likely leading to exposure misclassification. For instance, we calculated traffic volumes and traffic densities from 2004 Caltrans data, reflecting traffic conditions near the midpoint of our study. This was a reasonable approach because spatial traffic gradients tend to remain stable over time, with a relatively homogenous increase in traffic volumes as population increases ([@c4], [@c5]). Any exposure misclassification introduced would likely be nondifferential, biasing results toward the null. Indeed, traffic effects appeared to be smaller in patients enrolled before 2004 and after 2009, although this effect modification did not reach statistical significance. Geocoding was not performed concurrently with patient enrollment, but rather during the analysis, using 2010--2011 geocoding reference data sets. This difference in timing introduced slight inaccuracies in geocoding the addresses of patients enrolled before or after the reference period, but the overall accuracy of the match remained high (score 93/100) with the exclusion of only 2% of TB patients owing to an inability to geocode addresses. Traffic exposure estimates were limited to residential addresses and did not account for microenvironments such as household air pollution, indoor and outdoor pollution at work or school locations, or commuting patterns. We did not estimate exposures to specific traffic-related air pollutants such as ${PM}_{2.5}$, $\text{NO}_{2}$, or ozone. Any misclassifications of exposure were likely randomly distributed, resulting in an underestimate of true adverse effects of TRAP on TB treatment outcomes. We only considered baseline home addresses and did not exclude those who moved to different addresses within California during follow-up. However, exclusion of movers in alternative Cox models did not alter mortality hazards. Determining the hazards of traffic exposures on cause-specific mortality would have been informative, but these data were not available. The differences in baseline characteristics by traffic density are likely a reflection of inherent socioeconomic differences present in those living in highly polluted areas rather than a reflection of selection bias given the similarities in baseline characteristics between those excluded and those included in the final survival analyses. The California TB Registry provided a wealth of covariates but no individual-level direct measures of poverty or tobacco smoking. Poverty could contribute to poor outcomes at multiple stages in the TB management cascade, from late presentation for diagnosis to lack of access to medical care for comorbidities to increased exposure to other risk factors. To address these limitations, in alternative models ([Table 4](#t4){ref-type="table"}), we adjusted for census block group household income and census-tract smoking prevalence, and we found that adjusting for group-level smoking augmented the effects of traffic exposure on mortality. However, to avoid misinterpretation of group-level data that could give rise to the ecologic fallacy ([@c19]), we only employed aggregate data in alternative models. Traffic data were not available for small local roads, which likely led to an underestimation of traffic densities at residential addresses and to the exclusion of patients who did not live near major roads. Excluded patients were similar to those included except for factors that appeared to be related to rural living, and of the included patients, 98% lived within the city limits. As such, our findings are not generalizable to TB patients living outside of towns and cities.

Conclusion {#s5}
==========

TB patients living in high-traffic neighborhoods were at increased risk for mortality during treatment even after controlling for demographic, socioeconomic, and clinical factors. Our findings suggest that TB patients are susceptible to the adverse health effects of traffic-related air pollution and that traffic exposure might be an important modifiable risk factor for poor TB treatment outcomes. These findings should be confirmed with additional studies to determine the effects of traffic-related pollutants, and of traffic measures in other settings, on tuberculosis outcomes.

Supplemental Material
=====================

###### 

Click here for additional data file.
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